fda warning letters compounded semaglutide tirzepatide september 2025 Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding Prescription Drug Freight Fraud, June

By frequent and prolonged vomiting, we mean that a patient will vomit several times a day for two weeks or more

This regulatory milestone arrives as consumer search interest for weight loss medications often increases around the New Year period

Application Insights Why Did the Type 2 Diabetes Mellitus Segment Dominate the GLP-1 Analogues Market in 2025

Medication alone is not enough to lose weight

Still basking in the afterglow of its Wegovy pill launch earlier this year, Novo Nordisk has achieved another victory as it strives to make the most out of its blockbuster GLP-1 drug in an increasingly pressured obesity market